Primary Systemic Amyloidosis Differential Diagnoses

1. Hayman SR, Bailey RJ, Jalal SM, et al. Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis. Blood. 2001 Oct 1. 98(7):2266-8. [QxMD MEDLINE Link].

2. Divry P, Florkin M, Firket J. Sur les proprietes otiques de l'amiloide. C R Soc Biol (Paris). 1927. 97:1808-10.

3. Cohen AS, Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature. 1959 Apr 25. 183(4669):1202-3. [QxMD MEDLINE Link].

4. Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005 Feb 15. 95(4):535-7. [QxMD MEDLINE Link].

5. Vaxman I, Gertz M. When to Suspect a Diagnosis of Amyloidosis. Acta Haematol. 2020. 143 (4):304-311. [QxMD MEDLINE Link].

6. Wong CK. Mucocutaneous manifestations in systemic amyloidosis. Clin Dermatol. 1990 Apr-Jun. 8(2):7-12. [QxMD MEDLINE Link].

7. Silverstein SR. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Dermatol Online J. 2005. 11(1):5. [QxMD MEDLINE Link].

8. McCormick RS, Sloan P, Farr D, Carrozzo M. Oral puprura as the first manifestation of primary systemic amyloidosos. Br J Oral Maxillofac Surg. 2015 Dec 17. [QxMD MEDLINE Link].

9. Iwahashi N, Tame E, Nagasaka T, Furuta M, Nagashima H, Nimura Y. Massive hemorrhage and pseudo-obstruction of the small intestine caused by primary AL amyloidosis associated with gastric cancer: report of a case. Surg Today. 2004. 34(10):871-4. [QxMD MEDLINE Link].

10. Kyle RA, Bayrd ED. Amyloidosis: Review of 236 cases. Medicine (Baltimore). 1975. 54:271-299. [QxMD MEDLINE Link].

11. Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983 Oct. 58(10):665-83. [QxMD MEDLINE Link].

12. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996 Mar. 100(3):290-8. [QxMD MEDLINE Link].

13. Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol. 2012 Sep 18. 60(12):1067-76. [QxMD MEDLINE Link].

14. Xingguang Lee L, Zhou P, Varga C, Fogaren T, Ho K, Ma X, et al. Daratumumab activity in relapsed or primary refractory systemic AL amyloidosis and Fcγ receptor 3A V158F polymorphisms. Amyloid. 2019 Jun. 26 (2):101-102. [QxMD MEDLINE Link].

15. Beatty PE, Killion L, Mc Hugh J, Tobin AM. Spontaneous bilateral peri-orbital purpura: an important clinical sign of primary systemic amyloidosis. BMJ Case Rep. 2021 Apr 1. 14 (4):[QxMD MEDLINE Link].

16. Lutz ME, Pittelkow MR. Progressive generalized alopecia due to systemic amyloidosis. J Am Acad Dermatol. 2002 Mar. 46(3):434-6. [QxMD MEDLINE Link].

17. Moura CG, Moura TG, Duraes AR, Souza SP. Exuberant macroglossia in a patient with primary systemic amyloidosis. Clin Exp Rheumatol. 2005 May-Jun. 23(3):428. [QxMD MEDLINE Link].

18. Xavier SD, Bussoloti IF, Muller H. Macroglossia secondary to systemic amyloidosis: case report and literature review. Ear Nose Throat J. 2005 Jun. 84(6):358-61. [QxMD MEDLINE Link].

19. Summers EM, Kendrick CG. Primary localized cutaneous nodular amyloidosis and CREST syndrome: a case report and review of the literature. Cutis. 2008 Jul. 82(1):55-9. [QxMD MEDLINE Link].

20. Villa F, Dionigi G, Tanda ML, Rovera F, Boni L. Amyloid goiter. Int J Surg. 2008 Dec 13. [QxMD MEDLINE Link].

21. Hassanandani T, Singh BSTP, Kar BR. Early Dermoscopic Signs Leading to Primary Systemic Amyloidosis' Diagnosis: A Case Report. Dermatol Pract Concept. 2021 Jul. 11 (3):e2021023. [QxMD MEDLINE Link].

22. Singh V, Fishman JE, Alfonso CE. Primary Systemic Amyloidosis Presenting as Constrictive Pericarditis. Cardiology. 2011 Jul 12. 118(4):251-255. [QxMD MEDLINE Link].

23. Desai HV, Aronow WS, Peterson SJ, Frishman WH. Cardiac amyloidosis: approaches to diagnosis and management. Cardiol Rev. 2010 Jan-Feb. 18(1):1-11. [QxMD MEDLINE Link].

24. Emmungil H, Kalfa M, Basarik B, Kahraman H, Tanhan F, Yaman B, et al. Primary systemic Al amyloidosis presenting as temporal arteritis. Case Rep Rheumatol. 2014. 2014:549641. [QxMD MEDLINE Link]. [Full Text].

25. Hayman SR, Lacy MQ, Kyle RA, Gertz MA. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med. 2001 Nov. 111(7):535-40. [QxMD MEDLINE Link].

26. Terrier B, Jaccard A, Harousseau JL, et al. The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients. Medicine (Baltimore). 2008 Mar. 87(2):99-109. [QxMD MEDLINE Link].

27. Cuddy SAM, Falk RH. Amyloidosis as a Systemic Disease in Context. Can J Cardiol. 2020 Mar. 36 (3):396-407. [QxMD MEDLINE Link].

28. Vaxman I, Dispenzieri A, Muchtar E, Gertz M. New developments in diagnosis, risk assessment and management in systemic amyloidosis. Blood Rev. 2020 Mar. 40:100636. [QxMD MEDLINE Link].

29. Dorbala S, Cuddy S, Falk RH. How to Image Cardiac Amyloidosis: A Practical Approach. JACC Cardiovasc Imaging. 2020 Jun. 13 (6):1368-1383. [QxMD MEDLINE Link].

30. Lee JH, Lee GY, Kim SJ, Kim KH, Jeon ES, Lee KH, et al. Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis. Nucl Med Mol Imaging. 2015 Sep. 49(3):[QxMD MEDLINE Link].

31. Picken MM. Modern approaches to the treatment of amyloidosis: the critical importance of early detection in surgical pathology. Adv Anat Pathol. 2013 Nov. 20(6):424-39. [QxMD MEDLINE Link].

32. Ueberdiek S, Kempf W, Kretschmer L, Peter Schön M, Mitteldorf C. AL-Amyloidoma of the Skin-A Rare Manifestation of Primary Cutaneous Marginal Zone Lymphoma. Am J Dermatopathol. 2019 Jul. 41 (7):518-521. [QxMD MEDLINE Link].

33. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997 Apr 24. 336(17):1202-7. [QxMD MEDLINE Link].

34. Shimojima Y, Matsuda M, Ishii W, et al. High-dose melphalan followed by autologous stem cell support in primary systemic AL amyloidosis with multiple organ involvement. Intern Med. 2005 May. 44(5):484-9. [QxMD MEDLINE Link].

35. Kyle RA, Greipp PR. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo. Blood. 1978 Oct. 52(4):818-27. [QxMD MEDLINE Link].

36. Dispenzieri A, Lacy MQ, Zeldenrust SR. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood. 2006 Sep 28. [QxMD MEDLINE Link].

37. Roy A, Roy V. Primary systemic amyloidosis. Early diagnosis and therapy can improve survival rates and quality of life. Postgrad Med. 2006 Jun-Jul. 119(1):93-9. [QxMD MEDLINE Link].

Judit H Nyirady, MD, MBA Adjunct Assistant Professor, Department of Dermatology, Rutgers New Jersey Medical School

Judit H Nyirady, MD, MBA is a member of the following medical societies: American Academy of Dermatology, European Academy of Dermatology and Venereology, Women's Dermatologic Society

Disclosure: Receiving salary from LEO Pharma Inc. for employment. for: LEO Pharma Inc.

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

David F Butler, MD Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Military Dermatologists, Phi Beta Kappa, Texas Dermatological Society

Disclosure: Nothing to disclose.

Edward F Chan, MD Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine

Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Takeji Nishikawa, MD Emeritus Professor, Department of Dermatology, Keio University School of Medicine; Director, Samoncho Dermatology Clinic; Managing Director, The Waksman Foundation of Japan Inc

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article